🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07442253
Starting soon Not applicable

Tidal Model-Based ACT for Depression

NCT07442253 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-02-26
Last updated
2026-03-02

Condition(s) studied

Depression - Major Depressive Disorder

Investigational drug(s) / intervention(s)

Tidal Model-based ACT

Tidal Model-based ACT: This intervention combines standard Transcranial Magnetic Stimulation (TMS) treatment with an 8-session Acceptance and Commitment Therapy (ACT)-based psychoeducation program structured specifically within the Tidal Model framework. Unlike standard ACT or TMS interventions alone, this program integrates mindfulness, value-based actions, and experiential exercises tailored for patients with depression receiving TMS, aiming to enhance meaning in life and conscious self-care.

Study summary

The purpose of this randomized controlled clinical trial is to evaluate the effectiveness of an Acceptance and Commitment Therapy (ACT)-oriented psychoeducation program based on the Tidal Model in patients diagnosed with depression who are receiving transcranial magnetic stimulation (TMS) treatment at a university hospital psychiatry clinic.

The primary objective of this study is to determine whether participation in the psychoeducation program improves meaning in life and conscious self-care compared to usual treatment alone. The main questions this study aims to answer are:

* Does the ACT-oriented psychoeducation program increase participants' level of meaning in life?
* Does the program improve conscious self-care behaviors in individuals with depression?

Participants will be randomly assigned to either an intervention group or a control group. The intervention group will receive an 8-week structured psychoeducation program in addition to standard TMS treatment. The control group will continue to receive standard treatment without additional psychoeducation.

Participants in the intervention group will attend weekly psychoeducation sessions focusing on psychological flexibility, values clarification, coping strategies, and self-care practices. Outcome measures will be collected at baseline, immediately after the intervention, and one month after completion of the program.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: Age between 18 and 65 years Receiving treatment for depression for at least 6 months Within the 6-month period following TMS treatment Able to communicate in Turkish without difficulty No hearing problems, cognitive impairments, or additional psychiatric disorders Willing to participate and has provided written informed consent Exclusion Criteria: Participant withdraws voluntarily from the study Relapse of depression during the study period requiring psychiatric hospitalization * Sİtuation in which participants do not attend two consecutive sessions Starting participants on other psychotropic medications (e.g., ANTIPSYCHOTIC, MOOD STABILIZER, etc.) IN ADDITION TO THEIR ongoing antidepressant or anxiolytic treatments, and additional psychotherapies other than the ACT intervention.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Gazi University Health Research and Application Center, Gazi Hospital Ankara Turkey (Türkiye)

More Baskent University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07442253 on ClinicalTrials.gov ↗ ← All trials in Turkey